The increasing adoption of targeted antibodies is expected to be one of the major driving factors for the growth of the antibody production market during the forecast period.
The global antibody production market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Browse Report Summary: www.scalarmarketresearch.com/market-reports/antibody-production-market
Key findings of the report:
- The increasing adoption of targeted antibodies is expected to be one of the major driving factors for the growth of the antibody production market during the forecast period.
- Apart from that, the rise in the research and development activities and the rapid patent expiration of the blockbuster antibodies are also attributed to be some of the major drivers for the antibody production market in the coming years.
- The increased approval rate of the therapeutic antibodies, rising demand for protein therapies, and the rising prevalence of the infectious diseases are also expected to be some of the significant drivers for the antibody production market during the forecast period.
Detailed segmentation of the antibody production market
The report segments the global antibody production market by the types of products, applications, and the major geographic segments.
The application segment of the market is further divided into polyclonal antibodies and monoclonal antibodies. Based on the major geographic regions, the report segments the global antibody production market into North America, Asia-Pacific, Europe, and Rest of the World.
Request Sample: www.scalarmarketresearch.com/request-sample.php?id=265
The antibody production market report provides analysis of the key players, including:
- Abbott Laboratories
- Abcam plc.
- Eli Lilly and Company
- GE Healthcare
- Genentech, Inc.
- GeneTex Inc.
- Merck KGaA
- Roche Diagnostics
- Sigma-Aldrich Co.
- Thermo Fisher Scientific, Inc.
For more information: